SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-006935
Filing Date
2020-05-07
Accepted
2020-05-07 16:04:22
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cerc10-q120200331.htm 10-Q 1100471
2 EXHIBIT 10.5 ex-105colaamendedemploymen.htm EX-10.5 23453
3 EXHIBIT 31.1 q12020cercex-311.htm EX-31.1 15658
4 EXHIBIT 31.2 q12020cercex-312.htm EX-31.2 15660
5 EXHIBIT 32.1 q12020cercex-321.htm EX-32.1 14436
12 pipelinechartfor10q1v2.jpg GRAPHIC 154232
  Complete submission text file 0001628280-20-006935.txt   7730433

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cerc-20200331.xml EX-101.INS 1388564
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20200331.xsd EX-101.SCH 61607
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20200331_cal.xml EX-101.CAL 87449
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20200331_def.xml EX-101.DEF 446043
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20200331_lab.xml EX-101.LAB 857330
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20200331_pre.xml EX-101.PRE 553907
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 20856247
SIC: 2834 Pharmaceutical Preparations